Why develop antidotes and reversal agents for non-vitamin K oral anticoagulants?
Crossref DOI link: https://doi.org/10.1007/s11239-015-1296-1
Published Online: 2015-10-26
Published Print: 2016-02
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Washam, Jeffrey B.
Piccini, Jonathan P.
Text and Data Mining valid from 2015-10-26
